Opko Health, Inc. OPK

OPK Company Overview

OPKO Health, Inc. is a diversified healthcare company operating across the biotechnology, diagnostics, and pharmaceutical industries. The company develops and commercializes diagnostic tests, specialty pharmaceuticals, biologics, and healthcare services, with operations spanning clinical laboratories, drug development, and medical technologies. OPKO’s primary revenue drivers have historically included laboratory testing services through BioReference Health, pharmaceutical products such as Rayaldee, and licensing or collaboration arrangements tied to its biologics pipeline. The company serves physicians, hospitals, healthcare systems, clinical researchers, and patients across multiple therapeutic categories, including endocrinology, nephrology, infectious disease, and oncology.

The company was founded in 1991 and is headquartered in Miami, Florida. OPKO evolved through a series of acquisitions and strategic investments that expanded its footprint beyond pharmaceutical development into diagnostics and laboratory services. A major milestone was the acquisition of Bio-Reference Laboratories in 2015, which significantly increased OPKO’s scale in diagnostic testing and healthcare services. The company has also pursued partnerships with larger pharmaceutical firms to advance drug candidates and biologics, positioning itself as an integrated healthcare company with exposure to both recurring diagnostic revenue and long-term pharmaceutical development opportunities.